Researchers have found a new link between exposure to ‘forever chemicals’ and one lifelong health condition. A Sweden-based ...

People with higher blood levels of certain manufactured compounds that persist in the environment are more likely to be ...

Sanofi will not be pursuing approval of tolebrutinib for PPMS, and an FDA decision on the therapy in nonrelapsing SPMS will ...

When the first spasm hit, it was sharp, sudden, and paralyzing. Tamika Luciano thought her life was ending. The entire left side of her body seized. Her face tightened, her limbs stiffened, and for ...

French drugmaker Sanofi on Monday flagged another delay to a U.S. regulatory decision for its experimental multiple sclerosis ...

Study suggests exposure to chemicals known as “forever chemicals” may significantly increase the likelihood of developing multiple sclerosis ...

A U.S. regulatory decision on tolebrutinib will again be delayed while a late-stage trial of the drug for a different form of ...

Multiple sclerosis (MS) is a disorder that prompts the body's immune system to attack myelin, the protective sheath covering nerve cells in the brain, optic nerve and spinal cord. This can in turn ...

WEDNESDAY, Dec. 17, 2025 (HealthDay News) — An over-the-counter supplement called lipoic acid might help slow the loss of ...

After taking a shot at becoming a neuroscience biotech, buzzy Bay Area AI outfit Verge Genomics is dropping its only clinical ...

If gut bacteria are too similar to the protective layer of nerves, they can misdirect the immune system and cause it to ...